Literature DB >> 10206979

Lipopolysaccharide-induced tumor necrosis factor-alpha promoter activity is inhibitor of nuclear factor-kappaB kinase-dependent.

J L Swantek1, L Christerson, M H Cobb.   

Abstract

The adverse effects of lipopolysaccharide (LPS) are primarily mediated by tumor necrosis factor-alpha (TNF-alpha). TNF-alpha production by LPS-stimulated macrophages is regulated both transcriptionally and post-transcriptionally. Transcriptional regulation of the TNF-alpha gene is dependent on nuclear factor-kappaB (NF-kappaB). We examined the signaling pathways involved in the regulation of NF-kappaB that lead to TNF-alpha promoter activity. We determined a role for one or both of the recently identified inhibitor of NF-kappaB kinases, IkappaB kinase-1 and IkappaB kinase-2, in LPS induction of an NF-kappaB reporter and of TNF-alpha promoter activity. IkappaB kinase activation is one of the earliest signaling events known to be induced by LPS. Furthermore, our results suggest roles for the IkappaB kinases NF-kappaB-inducing kinase and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 in the regulation of IkappaB kinase-2, as well as in LPS-induced TNF-alpha transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206979     DOI: 10.1074/jbc.274.17.11667

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Luteolin prevents LPS-induced TNF-α expression in cardiac myocytes through inhibiting NF-κB signaling pathway.

Authors:  Lihua Lv; Linhua Lv; Yubi Zhang; Qiuhuan Kong
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

3.  Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages.

Authors:  Junko Nishioka; Chihiro Iwahara; Mikiko Kawasaki; Fumiko Yoshizaki; Hitoshi Nakayama; Kenji Takamori; Hideoki Ogawa; Kazuhisa Iwabuchi
Journal:  Inflamm Res       Date:  2011-10-18       Impact factor: 4.575

Review 4.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

5.  Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

Authors:  S Beinke; M J Robinson; M Hugunin; S C Ley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 6.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.

Authors:  Sören Beinke; Steven C Ley
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

7.  LPS suppresses expression of asialoglycoprotein-binding protein through TLR4 in thioglycolate-elicited peritoneal macrophages.

Authors:  Bruce Yong Ma; Mio Kaihama; Motohiro Nonaka; Shogo Oka; Nobuko Kawasaki; Toshisuke Kawasaki
Journal:  Glycoconj J       Date:  2007-03-07       Impact factor: 2.916

Review 8.  Regulation of chemokine expression by antiinflammatory cytokines.

Authors:  Thomas A Hamilton; Yoshihiro Ohmori; Julie Tebo
Journal:  Immunol Res       Date:  2002       Impact factor: 4.505

9.  The deubiquitinating enzyme, ubiquitin-specific peptidase 50, regulates inflammasome activation by targeting the ASC adaptor protein.

Authors:  Jae Young Lee; Dongyeob Seo; Jiyeon You; Sehee Chung; Jin Seok Park; Ji-Hyung Lee; Su Myung Jung; Youn Sook Lee; Seok Hee Park
Journal:  FEBS Lett       Date:  2017-01-29       Impact factor: 4.124

10.  CD97/ADGRE5 Inhibits LPS Induced NF-κB Activation through PPAR-γ Upregulation in Macrophages.

Authors:  Shuai Wang; Zewei Sun; Wenting Zhao; Zhen Wang; Mingjie Wu; Yanyun Pan; Hui Yan; Jianhua Zhu
Journal:  Mediators Inflamm       Date:  2016-02-21       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.